As no pharmacological inhibitor of MCT4 is yet available and as previous published results [17] showed that the major pro-tumour action of BSG is mediated through bioenergetics, namely by controlling lactate transport, we decided to knockdown both MCT4 and BSG. The gene discussed is BSG; the disease is neoplasm.